ID   KYSE-360
AC   CVCL_G699
SY   KYSE 360; KYSE360
DR   Wikidata; Q54900827
RX   PubMed=1728357;
RX   PubMed=7913084;
CC   Population: Japanese.
CC   Doubling time: 61.6 hours (PubMed=1728357).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
RX   PubMed=7913084; DOI=10.1002/ijc.2910580224;
RA   Kanda, Yuji
RA   Nishiyama, Yasuyuki
RA   Shimada, Yutaka
RA   Imamura, Masayuki
RA   Nomura, Hiroshi
RA   Hiai, Hiroshi
RA   Fukumoto, Manabu
RT   "Analysis of gene amplification and overexpression in human
RT   esophageal-carcinoma cell lines.";
RL   Int. J. Cancer 58:291-297(1994).
//
RX   PubMed=1728357; DOI=10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C;
RA   Shimada, Yutaka
RA   Imamura, Masayuki
RA   Wagata, Takashi
RA   Yamaguchi, Nozomi
RA   Tobe, Takayoshi
RT   "Characterization of 21 newly established esophageal cancer cell
RT   lines.";
RL   Cancer 69:277-284(1992).
//